Literature DB >> 9562107

The use of restriction fragment length polymorphism (RFLP) analysis for epidemiological studies of tuberculosis in developing countries.

D L Cohn1, R J O'Brien.   

Abstract

DNA fingerprinting, of which restriction fragment length polymorphism (RFLP) typing is the most common method used, has permitted novel investigations of the epidemiology and pathogenesis of tuberculosis. The use of IS6110, an insertion sequence which is present in Mycobacterium tuberculosis, is generally considered to be the standard RFLP method, but other molecular typing techniques may be used as adjuncts in selected circumstances. A number of epidemiologic studies using RFLP typing have been done in both industrialized and developing countries. The major findings include the confirmation or identification of chains of transmission (of both drug-sensitive and drug-resistant strains of tuberculosis), distribution of strain clusters within populations, differentiation of relapse from exogenous reinfection, better understanding of the pathogenesis of tuberculosis, identification of laboratory cross-contamination, and insight into the molecular evolution of the species. For developing countries, where the burden of tuberculosis is greatest, three major areas of investigation for the use of RFLP analysis in epidemiologic studies of tuberculosis have been identified: 1) community transmission, 2) nosocomial transmission, and 3) human immunodeficiency virus (HIV)-related tuberculosis. Elements of protocols are suggested which can be used by investigators to perform well-designed epidemiologic studies which will be relevant to developing countries and which are likely to have an impact on control programmes in these settings.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9562107

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  9 in total

1.  Molecular and conventional epidemiology of Mycobacterium tuberculosis in Botswana: a population-based prospective study of 301 pulmonary tuberculosis patients.

Authors:  S Lockman; J D Sheppard; C R Braden; M J Mwasekaga; C L Woodley; T A Kenyon; N J Binkin; M Steinman; F Montsho; M Kesupile-Reed; C Hirschfeldt; M Notha; T Moeti; J W Tappero
Journal:  J Clin Microbiol       Date:  2001-03       Impact factor: 5.948

2.  Recent Developments in Epidemiology, Treatment, and Diagnosis of Tuberculosis.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-04       Impact factor: 3.725

Review 3.  Tuberculosis and HIV Coinfection.

Authors:  Judith Bruchfeld; Margarida Correia-Neves; Gunilla Källenius
Journal:  Cold Spring Harb Perspect Med       Date:  2015-02-26       Impact factor: 6.915

4.  Restriction fragment length polymorphism analysis of Mycobacterium tuberculosis isolated from countries in the western pacific region.

Authors:  Y K Park; G H Bai; S J Kim
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

5.  Molecular epidemiology and drug resistance of Mycobacterium tuberculosis isolates from Ethiopian pulmonary tuberculosis patients with and without human immunodeficiency virus infection.

Authors:  Judith Bruchfeld; Getachew Aderaye; Ingela Berggren Palme; Bjarne Bjorvatn; Solomon Ghebremichael; Sven Hoffner; Lars Lindquist
Journal:  J Clin Microbiol       Date:  2002-05       Impact factor: 5.948

6.  Human immunodeficiency virus increases the risk of tuberculosis due to recent re-infection in individuals with latent infection.

Authors:  R M G J Houben; J R Glynn; K Mallard; L Sichali; S Malema; P E M Fine; N French; A C Crampin
Journal:  Int J Tuberc Lung Dis       Date:  2010-07       Impact factor: 2.373

7.  Community-randomized trial of enhanced DOTS for tuberculosis control in Rio de Janeiro, Brazil.

Authors:  S C Cavalcante; B Durovni; G L Barnes; F B A Souza; R F Silva; P F Barroso; C I Mohan; A Miller; J E Golub; R E Chaisson
Journal:  Int J Tuberc Lung Dis       Date:  2010-02       Impact factor: 2.373

8.  Two-dimensional DNA displays for comparisons of bacterial genomes.

Authors:  Chad Malloff; Edie Dullaghan; Alice Li; Richard Stokes; Rachel Fernandez; Wan Lam
Journal:  Biol Proced Online       Date:  2003-06-15       Impact factor: 3.244

9.  Identification of a predominant isolate of Mycobacterium tuberculosis using molecular and clinical epidemiology tools and in vitro cytokine responses.

Authors:  M Kaushal Sharma; A Al-Azem; J Wolfe; E Hershfield; A Kabani
Journal:  BMC Infect Dis       Date:  2003-04-08       Impact factor: 3.090

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.